Logo 773 Pill - orange capsule/oblong, 17mm
Generic Name: simvastatin/sitagliptin
Pill with imprint Logo 773 is Orange, Capsule/Oblong and has been identified as Juvisync simvastatin 40 mg / sitagliptin 100 mg. It is supplied by Merck & Co., Inc.
Juvisync is used in the treatment of High Cholesterol; Cardiovascular Risk Reduction; High Cholesterol, Familial Heterozygous; High Cholesterol, Familial Homozygous; Type 2 Diabetes and belongs to the drug classes antidiabetic combinations, antihyperlipidemic combinations. Not for use in pregnancy. Juvisync simvastatin 40 mg / sitagliptin 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Logo 773
Juvisync
- Generic Name
- simvastatin/sitagliptin
- Imprint
- Logo 773
- Strength
- simvastatin 40 mg / sitagliptin 100 mg
- Color
- Orange
- Size
- 17.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Antidiabetic combinations, Antihyperlipidemic combinations
- Pregnancy Category
- X - Not for use in pregnancy
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Merck & Co., Inc.
- National Drug Code (NDC)
- 00006-0773 (Discontinued)
- Inactive Ingredients
-
calcium phosphate dibasic anhydrous,
microcrystalline cellulose,
croscarmellose sodium,
sodium stearyl fumarate,
magnesium stearate,
ascorbic acid,
citric acid monohydrate,
lactose monohydrate,
corn starch,
polyvinyl alcohol,
polyethylene glycol 3350,
magnesium silicate,
titanium dioxide,
ferric oxide red,
ferric oxide yellow,
ferrosoferric oxide,
butylated hydroxyanisole
Note: Inactive ingredients may vary.
Related images for "Logo 773"
More about Juvisync (simvastatin / sitagliptin)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: antidiabetic combinations
Patient resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.